BusinessActinium Pharmaceuticals to Present at 19th Annual Bio€quity Europe Conference in Ghent, BelgiumBy Nasdaq OMXMay 8, 2018, 11:30 AM UTC
BusinessAchillion Reports First Quarter 2018 Financial Results and Management TransitionBy Nasdaq OMXMay 2, 2018, 10:35 AM UTC
BusinessUPDATE: Puration Announces Plans To Produce THC Infused Beverage For Legal Canadian Recreational Marijuana MarketBy Nasdaq OMXMay 1, 2018, 2:44 PM UTC
BusinessTherapeutic Solutions International Launches Multi-Protocol Cancer Immunotherapy Clinical Trial with Pan Am Cancer TreatmentBy Nasdaq OMXMay 1, 2018, 1:02 PM UTC
BusinessActinium Pharmaceuticals Appoints Dr. Jeffrey Chell, Bone Marrow Transplant Visionary and Chief Executive Officer Emeritus of Be The Match and National Marrow Donor Program, to its Board of DirectorsBy Nasdaq OMXMay 1, 2018, 11:31 AM UTC
BusinessLexington Releases Audited Consolidated Financial StatementsBy Nasdaq OMXMay 1, 2018, 12:18 AM UTC
BusinessThe Epilepsy Foundation Launches a New Research Study to Find Biomarkers for Treatment of Focal Seizures in People with EpilepsyBy Nasdaq OMXApr 24, 2018, 12:06 PM UTC
BusinessCellAegis Announces First Distribution Agreement for autoRIC® in EuropeBy Nasdaq OMXApr 24, 2018, 11:00 AM UTC
